Climb Bio, Inc.

CLYM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$87,229$93,112$43,585$46,922
Short-Term Investments$63,690$13,686$79,981$89,558
Receivables$1,119$2,464$6,492$6,523
Inventory$0$0$0$0
Other Curr. Assets$2,834$993$4,335$5,249
Total Curr. Assets$154,872$110,255$134,393$148,252
Property Plant & Equip (Net)$490$199$471$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$61,610$0$0$24,919
Tax Assets$0$0$0$0
Other NC Assets$215$15$128$70
Total NC Assets$62,315$214$599$24,989
Other Assets$0$0$0$0
Total Assets$217,187$110,469$134,992$173,241
Liabilities
Payables$705$66$750$1,404
Short-Term Debt$157$334$300$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,069$2,433$5,047$4,627
Total Curr. Liab.$4,931$2,833$6,097$6,031
LT Debt$375$15$180$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$22$0$7
Total NC Liab.$375$37$180$7
Other Liabilities$0$0$0$0
Cap. Leases$532$349$480$0
Total Liabilities$5,306$2,870$6,277$6,038
Equity
Pref Stock$0$0$0$0
Common Stock$7$3$3$3
Retained Earnings-$229,876-$155,979-$120,860-$75,616
AOCI$23-$2-$358-$123
Other Equity$441,727$263,577$249,930$242,939
Total Equity$211,881$107,599$128,715$167,203
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$217,187$110,469$134,992$173,241
Net Debt-$86,697-$92,763-$43,105-$46,922
Climb Bio, Inc. (CLYM) Financial Statements & Key Stats | AlphaPilot